This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous. Find sources: "Adnan Kisa" – news · newspapers · books · scholar · JSTOR (October 2017) (Learn how and when to remove this message) The topic of this article may not meet Wikipedia's notability guideline for biographies. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Adnan Kisa" – news · newspapers · books · scholar · JSTOR (October 2017) (Learn how and when to remove this message) This article's lead section may be too short to adequately summarize the key points. Please consider expanding the lead to provide an accessible overview of all important aspects of the article. (November 2018) (Learn how and when to remove this message)

Adnan Kisa is a Turkish health policy and economic expert.

Kisa received a B.Sc. from Hacettepe University, master's degrees from Meharry Medical College and Istanbul University, and a doctorate in health policy and economics from Tulane University.^[1]

Kisa has worked as faculty and administrator at the University of Oslo and Baskent University, adjunct faculty at Tulane University, Gazi, Ahmet Yesevi, and Zirve Universities.^{[citation needed]} Kisa was selected for and provided a full scholarship for his master's and doctoral education between 1992 and 1998 in order to understand and bring the experiences of the US health system and the US policy back to Turkey.^[2]

Kisa has administered many scientific projects and worked as a consultant; as Health Economics and Policy Manager of Wyeth Pharmaceuticals, he conducted the economic evaluation of a pneumococcal 7-valent conjugate vaccine for the national immunization list for Turkey. He was principal investigator of WHO WHS-Turkey, principal investigator of the National Burden of Disease and Cost-Effectiveness of Essential Health Services in Turkey, a consultant in WHO-ICC,^[3] PM of the Strengthening Management in Reproductive Health Services Project, a member of The Network of Innovators of the Chronic Conditions of the WHO,^[4] and a PE team member of the INFINITY Project at Tulane and the Perinatal Outcome Study MMC.^{[citation needed]}

Kisa has more than 90 peer-reviewed published articles, books, book chapters, and research reports in English, Russian, Spanish, French, and Turkish. He is a member of many national and international health institutions, scientific boards, and editorial boards. He is the author, scientific writer, or editor of:

• Social Determinants of Healthcare Utilization in Dubai (LAP Lambert Academic Publishing, 2016)^{[citation needed]}
• "Innovative Care for Chronic Conditions: Building Blocks for Action"^[5] (World Health Organization, 2002, Geneva)
• "Adherence to Long-term Therapies: Evidence for Action Report"^[6] (World Health Organization, 2003, Geneva)^{[citation needed]}
• "Health Care Management" (Anadolu University Publications, 2007)^{[citation needed]}
• World Health Systems – Global Engagement in Creating Financially Viable Healthcare Systems Proceedings book (2002)^{[citation needed]}
• Proceedings: Sixth International Conference on Healthcare Systems (2010)^{[citation needed]}
• Introduction to Health Economics (1999)^{[citation needed]}